Melatonina Teva (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, signalling that it is night time. This interaction reduces neuronal activity that promotes wakefulness, aligns the internal clock with external darkness, and encourages the transition to sleep.

The appropriate dose of Melatonina Teva is determined by the prescribing clinician based on the patient’s age, condition severity, and response to therapy. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting Melatonina Teva.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melatonina Teva differs from traditional hypnotics such as zolpidem or benzodiazepines because it works by mimicking a natural hormone rather than depressing the central nervous system. This mechanism often results in fewer next‑day residual effects, but efficacy may be lower for severe insomnia, where prescription hypnotics might be preferred.

Store Melatonina Teva at ambient temperature below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Melatonina Teva is taken orally, usually with a glass of water. It is commonly administered 30–60 minutes before the desired bedtime, but patients should follow the timing recommended by their prescriber.

Serious adverse reactions, though rare, include severe allergic responses (rash, swelling, anaphylaxis), significant mood changes such as depression or suicidal thoughts, seizures, marked hypotension, and cardiac arrhythmias. Any of these symptoms require immediate medical attention.

Individuals with known hypersensitivity to melatonin or any excipients in the formulation should avoid the product. Patients taking certain anticoagulants, immunosuppressants, or strong CYP1A2 inhibitors should consult their physician, as should those with uncontrolled hypertension, severe depression, or a history of seizures.